Other
Group E
Group E is an intervention with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed267%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Effects of Electronic Cigarettes on Lung Biology
NCT02188511
completed
Evaluation of the Relationship Between Airway Measurements and Laryngoscopic View in Newborn and Infants
NCT03920748
completednot_applicable
Effect of Breathing Circuits on Intraoperative Body Temperature
NCT01831843
Clinical Trials (3)
Showing 3 of 3 trials
NCT02188511Not Applicable
Effects of Electronic Cigarettes on Lung Biology
NCT03920748
Evaluation of the Relationship Between Airway Measurements and Laryngoscopic View in Newborn and Infants
NCT01831843Not Applicable
Effect of Breathing Circuits on Intraoperative Body Temperature
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3